Datavault AI Inc. (NASDAQ: DVLT) has announced a binding term sheet with Wellgistics Health (NASDAQ: WGRX) to form DelivMeds AI, a comprehensive healthcare platform that integrates artificial intelligence, blockchain-enabled smart contracts, and biometric verification for direct-to-consumer healthcare delivery. The venture, which combines three concurrent transactions, carries an expected approximate asset value of $4 billion, subject to an independent fairness opinion.
The transactions include an expanded PharmacyChain™ license, the acquisition of QOLPOM intellectual property, and a controlling stake in Tollo Health. These moves are intended to support a national rollout of data-driven healthcare delivery and patient engagement solutions, leveraging Datavault AI's expertise in AI-driven data experiences and valuation within the Web 3.0 environment.
Datavault AI's platform, as detailed in the press release, operates through two primary divisions: Acoustic Sciences and Data Science. The Acoustic Sciences division features patented technologies including WiSA®, ADIO®, and Sumerian®, focusing on spatial and multichannel wireless high-definition sound transmission. The Data Science division utilizes Web 3.0 and high-performance computing to provide solutions for data perception, valuation, and secure monetization, serving industries such as sports & entertainment, biotech, fintech, real estate, healthcare, and energy.
The Information Data Exchange® enables Digital Twins and the licensing of name, image, and likeness by anchoring to immutable metadata, fostering responsible AI. The company's technology suite offers AI- and machine-learning-based automation, third-party integration, and detailed analytics. Headquartered in Philadelphia, PA, Datavault AI is positioning itself at the intersection of AI, blockchain, and healthcare.
For leaders in business and technology, this development signals a significant shift toward integrated, data-driven healthcare solutions that could streamline pharmacy operations, enhance patient engagement, and improve security through biometric verification. The $4 billion valuation underscores the potential scale and impact of combining AI with healthcare delivery, particularly in the context of direct-to-consumer models that are gaining traction post-pandemic.
Industry observers will be watching how DelivMeds AI navigates regulatory landscapes and integrates the acquired technologies to deliver on its promise of data-driven care. The partnership between Datavault AI and Wellgistics Health highlights a growing trend of convergence between AI companies and healthcare providers, aiming to unlock efficiencies and new revenue streams. More information about Datavault AI is available at www.dvlt.ai, and the latest news can be found in the company's newsroom at https://ibn.fm/DVLT.
